Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (221-230 of 418) with videos related to

Pageof 42
Sort By:
Plos One|August 1, 2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-AnalysisBruno Vincenzi, Massimo Di Maio, Marianna Silletta, et al.
Cancer Treatment Reviews|September 5, 2022
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysisLucia Musacchio, Anna Amela Valsecchi, Vanda Salutari, et al.
Breast (Edinburgh, Scotland)|September 1, 2018
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patientsMatteo Lambertini, Massimo Di Maio, Olivia Pagani, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 30, 2019
Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?Juan Gómez Rivas, Diego M Carrion, Mario Alvarez-Maestro, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year surveyAlessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Filippo de Marinis, Massimo Di Maio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.
The Oncologist|May 14, 2025
Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecanAnna Amela Valsecchi, Simona Pisegna, Andrea Antonuzzo, et al.
ESMO Open|October 14, 2020
Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) studyOrnella Garrone, Andrea Michelotti, Matteo Paccagnella, et al.
Pageof 42

Showing results (221-230 of 418) with videos related to

Sort By:
Pageof 42
Plos One|August 1, 2015
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-AnalysisBruno Vincenzi, Massimo Di Maio, Marianna Silletta, et al.
Cancer Treatment Reviews|September 5, 2022
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysisLucia Musacchio, Anna Amela Valsecchi, Vanda Salutari, et al.
Breast (Edinburgh, Scotland)|September 1, 2018
The BCY3/BCC 2017 survey on physicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in young breast cancer patientsMatteo Lambertini, Massimo Di Maio, Olivia Pagani, et al.
Journal of Biomedicine & Biotechnology|June 11, 2011
Gefitinib in non small cell lung cancerRaffaele Costanzo, Maria Carmela Piccirillo, Claudia Sandomenico, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|July 30, 2019
Bone-targeted therapy in castration-resistant prostate cancer: where do we stand?Juan Gómez Rivas, Diego M Carrion, Mario Alvarez-Maestro, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2005
Prospective clinical trials of biotherapies in solid tumors: a 5-year surveyAlessandro Ottaiano, Ernesto Mollo, Giuseppe Di Lorenzo, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2012
Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Filippo de Marinis, Massimo Di Maio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Second-line treatment of advanced non-small cell lung cancerCesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, et al.
The Oncologist|May 14, 2025
Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecanAnna Amela Valsecchi, Simona Pisegna, Andrea Antonuzzo, et al.
ESMO Open|October 14, 2020
Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) studyOrnella Garrone, Andrea Michelotti, Matteo Paccagnella, et al.
Pageof 42